Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II-Study With Nelarabine in Patients With Refractory Oder Relapsed T- ALL or T-lymphoblastic Lymphoma (Amend.7)

NCT00684619 is registered in ClinicalTrials.gov with Goethe University as lead sponsor.

NCT NCT00684619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00684619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II-Study With Nelarabine in Patients With Refractory Oder Relapsed T- ALL or T-lymphoblastic Lymphoma (Amend.7)
Lead sponsor
Goethe University
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
December 31, 2008
Enrollment
120 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

t-all, t-nhl (lymphoblastic)